03:47 PM EST - ProMIS Neurosciences : Announced initiation of a Cohort Study to evaluate the prevalence of different strains of Amyloid beta (Ab) prions in patients with Alzheimer's disease. ProMIS Neurosciences
shares T.PMN are trading unchanged at $0.14.
